Medication - Articles - Page 3

CLINICAL UPDATE

How to Use Lamotrigine

January 1, 2021

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Lamotrigine is approved for the prevention of bipolar episodes, but Dr. Aiken explains why it may also treat active bipolar depression. This mood stabilizer is among the most tolerable in its class, and has additional benefits in OCD, borderline personality disorder, and depersonalization disorder.

EXPERT Q&A

Alternative Therapies for SUDs

December 10, 2020

Steven Novella, MD

Steven Novella, MD
Assistant Professor of Neurology, Yale School of Medicine. Dr. Novella has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Not all alternative therapies are created equal. In this interview with Dr. Steven Novella, we discuss the prevalence of alternative therapies among patients with substance use disorders (SUDs) as well as the state of evidence for (or against) commonly utilized forms of complementary and alternative treatments for SUDs.

“What About the Implant, Doc?” Appraising Various Formulations of Buprenorphine

August 6, 2020

Edmund S. Higgins, MD.

Edmund S. Higgins, MD. Clinical Associate Professor of Psychiatry and Family Medicine, MUSC, Charleston, SC. Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Buprenorphine can be administered via intravenous, transdermal, sublingual, buccal, and implanted formulations. We appraise the evidence for various formulations and suggest certain populations for which certain formulations may be a better choice.

Updated Guidelines for Treating Opioid Use Disorder

August 6, 2020

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity

The American Society of Addiction Medicine released updated guidelines for the management of opioid use disorder (OUD) in March, 2020. They focus on expanding access to methadone and buprenorphine. Additionally, detailed guidance is given for perioperative management of OUD and pain management in patients with OUD.

EXPERT Q&A

Reduced Life Expectancy in ADHD

February 11, 2020

Russell Barkley, PhD

Russell Barkley, PhD
Clinical Professor of Psychiatry at The Virginia Commonwealth University Medical Center, Department of Psychiatry and the Virginia Treatment Center for Children Dr. Barkley has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Russell Barkley, PhD, discusses the enormity of the health consequences and early mortality associated with ADHD. The range and likely mechanism of long-term effects of ADHD are discussed, and we examine the role of assertive treatment in childhood and adolescence.

Can Stimulants Prevent Crime?

February 11, 2020

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The link between ADHD and antisocial behavior leading to arrests and incarcerations is often not clear: is the ADHD causing the behaviors or other related factors? We examine the results of a population-based study to give us insight into whether treating ADHD with stimulant medication has an effect on the risk of criminal behavior.

Methylphenidate Max Dosing

February 11, 2020

Thomas Jordan, MD.

Thomas Jordan, MD. Dr. Jordan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We examine current methylphenidate dosing and unpack what the research tells us about prescribing beyond conventional limits when clinically indicated for children and adolescents.

PrEP: Introduction to the Basics

November 22, 2019

With the rate of new HIV infections at just under 40,000 new infections per year, it is important for addiction practitioners to be on the front lines of HIV prevention. This article and corresponding table cover the pre-exposure prophylaxis (PrEP) with Truvada.

Perioperative Management of Patients on Buprenorphine Maintenance

November 22, 2019

Gregory Acampora, MD

Gregory Acampora, MD

Psychiatrist, Pain Management Center, Massachusetts General Hospital/Harvard Center for Addiction Medicine, Boston, MA. Assistant Professor, Harvard Medical School.

Dr. Acampora has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

For patients on buprenorphine maintenance facing surgery, it is crucial to balance the need to minimize pain while addressing the risk of relapse. In this interview, Dr. Gregory Acampora guides us through the specifics on perioperatively managing patients on varying doses of buprenorphine maintenance.

Varenicline and Bupropion: Soaring Again With EAGLES?

November 22, 2019

Nicholas Rosenlicht, MD.

Nicholas Rosenlicht, MD. Dr. Rosenlicht has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

This research update unpacks the details behind the landmark “EAGLES” trial (Evaluating Adverse Events in a Global Smoking Cessation Study), which led to the removal of the varenicline black box warning.